P POMPEIA LIFE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

P POMPEIA LIFE Trademark

Serial Number: 79367371 • Registration: 7656307

P POMPEIA LIFE is a trademark filed by MARIA FÁTIMA DE POMPEIA VIEGAS on January 11, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MARIA FÁTIMA DE POMPEIA VIEGAS

Vallés, 18

Entity Type: 01

Trademark Details

Filing Date

January 11, 2023

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; non-medicinal dentifrices; essential oils; face and body oils; massage oils; Non-medicated soaps; bath gel; shower gels; moisturizing creams; cosmetics in the nature of moisturizing lotions for the skin; cosmetics in the nature of moisturizing gels; bath and shower gels, non-medicated; nonmedicated vaginal washes for intimate hygiene or being deodorants; non-medicated intimate hygiene cleansers for sanitary use or used as deodorants; non-medicinal cleansing preparations for intimate hygiene; none of the above including perfumery products

Dietetic substances and foodstuffs for medical use; food supplements for persons; multi-vitamin preparations; vitamin supplements; vitamin preparations; vitamin and mineral supplements; Nutritional supplements; pharmaceutical products for the treatment of hemorrhoids and anal fissures; sanitary preparations for medical use; medicated moisturizing creams for pharmaceutical use; hygienic and sanitary products for medical use; disinfectants; sanitary tampons; sanitary pads; dermatological products; medicinal creams; hygienic personal lubricants; personal sexual lubricants; body lubricants for medical use; vaginal lubricants; vaginal moisturizers

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 31, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 31, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 21, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 5, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 7, 2024 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 30, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 11, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 11, 2024 OPNR
ATTORNEY REVIEW COMPLETED
Jun 20, 2024 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jun 11, 2024 LIME
NON-FINAL ACTION WRITTEN
May 23, 2024 CNRT
LIMITATION OF GOODS RECEIVED FROM IB
Apr 28, 2024 LIMG
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 17, 2023 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 12, 2023 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 12, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 11, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 5, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 13, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 24, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 13, 2023 REPR